Form 4: Anixa Biosciences Director Arnold M. Baskies Acquires 10,000 Shares
SEC Form 4 Filing
Anixa Biosciences Director Arnold M. Baskies purchased 10,000 shares of common stock at $3.63 per share on March 15, 2024.
Summary
- On March 15, 2024, Arnold M. Baskies, a director of Anixa Biosciences Inc., acquired 10,000 shares of common stock.
- The purchase price was $3.63 per share.
- Following the transaction, Baskies directly owns 110,000 shares of Anixa Biosciences Inc.
Sentiment
Score: 5
Explanation: The document is a neutral report of a transaction. It doesn't inherently convey positive or negative sentiment.
Industry Context
This Form 4 filing is a routine disclosure of insider trading activity, which is common for directors and officers of publicly traded companies. It provides transparency into the trading activities of company insiders.
Stakeholder Impact
- The purchase of shares by a director could be viewed positively by shareholders as it signals confidence in the company's future.
Key Dates
| Date | Description |
|---|---|
| 03/15/2024 | Date of transaction: Arnold M. Baskies purchased 10,000 shares of Anixa Biosciences Inc. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.